Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

Eitemau Tebyg

• Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome
  gan: Duret, Pierre-Marie, et al.
  Cyhoeddwyd: (2020)
• No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
  gan: Gottenberg, Jacques-Eric, et al.
  Cyhoeddwyd: (2006)
• Lack of efficacy of rituximab in Felty's syndrome
  gan: Sordet, C, et al.
  Cyhoeddwyd: (2005)
• EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
  gan: Seror, Raphaèle, et al.
  Cyhoeddwyd: (2010)
• Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
  gan: Gottenberg, J, et al.
  Cyhoeddwyd: (2005)